Sign in
BIOT Stock Price, Chart, Stats & News
L&G Pharma Breakthrough UCITS ETF
Save
L&G Pharma Breakthrough UCITS ETF (BIOT) does not currently pay a dividend.
Sector Equity Biotechnology
Category
0.49%
Expense ratio
–
Assets
29.21%
1Y return
BIOT chart
1M
3M
1Y
5Y
Loading chart...
About
The L&G Pharma Breakthrough UCITS ETF is designed to mirror the financial performance generated by the Solactive Pharma Breakthrough Value Index.
Top 10 BIOT holdings
| Holding | Ownership |
|---|---|
Health care 5.71% | |
Health care 4.34% | |
Health care 3.73% | |
Health care 3.55% | |
Health care 3.46% | |
Health care 3.15% | |
Health care 3.12% | |
Health care 3.09% | |
Health care 3.07% | |
Health care 3.04% |
Similar securities
Based on sector and market capitalization
Report issue